99%+ Purity
COA Included
Sealed Vials
VIP
Vasoactive intestinal peptide
Vasoactive intestinal peptide
Key Benefits
- May support vascular smooth muscle relaxation
- Research suggests anti-inflammatory immune modulation
- Promotes vasodilation through receptor activation
- May support pulmonary vascular function
- Demonstrates tissue protective properties
- Enables precise experimental dosing control
- Supports cardiovascular research applications
Fix Your Blood Flow—Finally Stop Fighting Your Circulation
Your cardiovascular system should work for you, not against you. VIP targets the exact receptors that control blood vessel relaxation, giving you direct pathway access to improved circulation and reduced inflammation. This is precision vascular support that actually addresses the underlying mechanisms instead of just masking symptoms.
Vascular smooth muscle relaxation / VPAC receptor-mediated vasodilation pathway
About VIP
VIP is a 28-amino acid peptide that naturally regulates blood vessel function and inflammatory responses throughout your body. It works by activating specific receptors that trigger smooth muscle relaxation and promote anti-inflammatory signaling. The result is improved blood flow, reduced vascular resistance, and enhanced tissue protection.
Who It's For
Ideal for individuals dealing with circulation challenges, chronic inflammation, or those pursuing advanced cardiovascular optimization protocols. VIP offers a direct approach to vascular health that works at the receptor level rather than through indirect pathways. Due to its short duration of action, it's typically used in targeted research applications where precise timing and control are essential.
Research Background
Vasoactive intestinal peptide (VIP) is a naturally occurring 28-amino acid neuropeptide that serves as both a neurotransmitter and hormone throughout the body. Originally discovered in the intestine, VIP has since been found to play crucial roles in cardiovascular regulation, immune system modulation, and inflammatory responses. The peptide works by binding to specific receptors (VPAC1 and VPAC2) found on various cell types, triggering signaling pathways that promote 1) smooth muscle relaxation leading to vasodilation, 2) anti-inflammatory effects through immune cell regulation, and 3) protective responses in tissues under stress. Research has particularly focused on VIP's potential in treating pulmonary arterial hypertension, where its ability to dilate blood vessels in the lungs could provide therapeutic benefit. Additional studies have explored its role in inflammatory bowel disease, asthma, and various autoimmune conditions due to its powerful anti-inflammatory properties. Despite promising preclinical results, the main challenge in developing VIP as a therapeutic has been its very short duration of action in the body, leading researchers to investigate modified versions and improved delivery methods to harness its therapeutic potential.
Dosing Protocol
| Level | Dose | |
|---|---|---|
Beginner | 50-100 mcg intranasal | |
Intermediate | 100-200 mcg intranasal | |
Advanced | 200-400 mcg intranasal |
Select a dosing level and click Calculate to plan your protocol.
Vials Required
2
12.6 mg needed ÷ 10 per vial
Total Investment
$130
$65.00 per vial
Per Dose
0.01 mL
2 units on U-100 syringe
Doses per Vial
66
10 ÷ 0.15 mg/dose
* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
VIP
$65.00